Biofrontera Inc. (NASDAQ:BFRI) Q4 2021 Earnings Conference Call April 8, 2022 11:00 AM ET
Company Participants
Tirth Patel - LHA IR
Hermann Lubbert - Executive Chairman
Erica Monaco - CEO
Conference Call Participants
Jonathan Aschoff - ROTH Capital Partners
Bruce Jackson - The Benchmark Company
Operator
Welcome to the Biofrontera Inc. Fourth Quarter and Full Year 2021 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Tirth Patel with LHA Investor Relations. Please go ahead.
Tirth Patel
Good morning, and welcome to Biofrontera Inc.'s fourth quarter and full year 2021 financial results conference call.
Please note that certain information discussed during today's call is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera's management will be making forward-looking statements and actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings. This conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, today, April 8, 2022. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.
During today’s call there will also be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP, nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in this morning’s press release.
With that, I would like to turn the call over to Hermann Lubbert, Executive Chairman of Biofrontera Inc.
Hermann Lubbert
Thank you, Tirth.
Welcome, everyone to Biofrontera Inc.'s 2021 fourth quarter and full year financial results conference call. Joining me today is Erica Monaco, Chief Executive Officer of Biofrontera Inc. In a moment, Erica will review the business, our strategy and our recent financial results. But first, I would like to provide a brief recap of our achievements during 2021.
The global dermatology market, and specifically the photodynamic therapy market experienced encouraging growth following a year of the depressed numbers of patients visits to dermatologists during the height of the COVID-19 pandemic.